Patents by Inventor Kenneth Stauderman
Kenneth Stauderman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240307384Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: ApplicationFiled: March 1, 2024Publication date: September 19, 2024Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
-
Publication number: 20240010638Abstract: Provided herein is an improved synthetic method for the production of CRAC channel inhibitors. The synthetic method provides a method for producing highly pure CRAC channel inhibitors for clinical testing.Type: ApplicationFiled: November 13, 2020Publication date: January 11, 2024Inventors: Kenneth STAUDERMAN, Michael DUNN, Kay OLMSTEAD
-
Patent number: 11752148Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: GrantFiled: March 16, 2021Date of Patent: September 12, 2023Assignee: CALCIMEDICA, INC.Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
-
Patent number: 11439639Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: GrantFiled: September 10, 2021Date of Patent: September 13, 2022Assignee: CALCIMEDICA, INC.Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
-
Publication number: 20220265645Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may he used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: ApplicationFiled: March 16, 2021Publication date: August 25, 2022Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
-
Patent number: 11311535Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: GrantFiled: February 26, 2016Date of Patent: April 26, 2022Assignee: CALCIMEDICA, INC.Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
-
Publication number: 20220000863Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: ApplicationFiled: September 10, 2021Publication date: January 6, 2022Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
-
Patent number: 11013737Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: GrantFiled: October 22, 2020Date of Patent: May 25, 2021Assignee: CALCIMEDIA, INC.Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
-
Patent number: 10973818Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: GrantFiled: October 22, 2020Date of Patent: April 13, 2021Assignee: CALCIMEDICA, INC.Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
-
Publication number: 20210038597Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: ApplicationFiled: October 22, 2020Publication date: February 11, 2021Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
-
Publication number: 20200368228Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: ApplicationFiled: August 7, 2020Publication date: November 26, 2020Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
-
Patent number: 10821109Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: GrantFiled: August 7, 2020Date of Patent: November 3, 2020Assignee: CALCIMEDICA, INC.Inventors: Gonul Velicelebi, Kenneth Stauderman, Michael Dunn, Jack Roos
-
Publication number: 20200101069Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.Type: ApplicationFiled: August 8, 2019Publication date: April 2, 2020Inventors: Kenneth STAUDERMAN, Michael DUNN, Sudarshan HEBBAR, Midori YENARI, Rachid KACIMI
-
Patent number: 10478435Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.Type: GrantFiled: August 5, 2016Date of Patent: November 19, 2019Assignees: CALCIMEDICA, INC., THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRSInventors: Kenneth Stauderman, Michael Dunn, Sudarshan Hebbar, Midori Yenari, Rachid Kacimi
-
Patent number: 10420766Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.Type: GrantFiled: August 5, 2016Date of Patent: September 24, 2019Assignees: CALCIMEDICA, INC., THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRSInventors: Kenneth Stauderman, Michael Dunn, Sudarshan Hebbar, Midori Yenari, Rachid Kacimi
-
Publication number: 20180235959Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.Type: ApplicationFiled: August 5, 2016Publication date: August 23, 2018Inventors: Kenneth STAUDERMAN, Michael DUNN, Sudarshan HEBBAR, Midori YENARI, Rachid KACIMI
-
Publication number: 20180235958Abstract: Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.Type: ApplicationFiled: February 26, 2016Publication date: August 23, 2018Inventors: Gonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
-
Publication number: 20070031814Abstract: Methods are provided for identifying agents that modulate intracellular calcium. Also provided are methods of modulating calcium within cells and methods of identifying proteins involved in modulating intracellular calcium.Type: ApplicationFiled: March 3, 2004Publication date: February 8, 2007Inventors: Jack Roos, Kenneth Stauderman, Gonul Velicelebi, Paul Digregorio, Kari Ohlsen
-
Publication number: 20040009537Abstract: Methods are provided for identifying agents that modulate intracellular calcium. Also provided are methods of modulating calcium within cells and treating disease by modulating intracellular calcium. Also provided are methods of screening for nucleic acids encoding candidate ion transport proteins and methods of identifying nucleic acids encoding ion transport proteins.Type: ApplicationFiled: January 13, 2003Publication date: January 15, 2004Inventors: Jack Roos, Kenneth Stauderman, Gonul Velicelebi